Cited by 1,103Gut microbiota and healthMicrobial Metabolites in Food BiotechnologyProbiotics and Fermented Foods

Short chain fatty acids in human gut and metabolic health

Open access
Blaak, E.E., Canfora, E.E., Theis, S., Frost, G., Groen, A.K., Mithieux, G., Nauta, A., Scott, K. +5 more·2020·Beneficial Microbes

Abstract

Evidence is accumulating that short chain fatty acids (SCFA) play an important role in the maintenance of gut and metabolic health. The SCFA acetate, propionate and butyrate are produced from the microbial fermentation of indigestible carbohydrates and appear to be key mediators of the beneficial effects elicited by the gut microbiome. Microbial SCFA production is essential for gut integrity by regulating the luminal pH, mucus production, providing fuel for epithelial cells and effects on mucosal immune function. SCFA also directly modulate host metabolic health through a range of tissue-specific mechanisms related to appetite regulation, energy expenditure, glucose homeostasis and immunomodulation. Therefore, an increased microbial SCFA production can be considered as a health benefit, but data are mainly based on animal studies, whereas well-controlled human studies are limited. In this review an expert group by ILSI Europe's Prebiotics Task Force discussed the current scientific knowledge on SCFA to consider the relationship between SCFA and gut and metabolic health with a particular focus on human evidence. Overall, the available mechanistic data and limited human data on the metabolic consequences of elevated gut-derived SCFA production strongly suggest that increasing SCFA production could be a valuable strategy in the preventing gastro-intestinal dysfunction, obesity and type 2 diabetes mellitus. Nevertheless, there is an urgent need for well controlled longer term human SCFA intervention studies, including measurement of SCFA fluxes and kinetics, the heterogeneity in response based on metabolic phenotype, the type of dietary fibre and fermentation site in fibre intervention studies and the control for factors that could shape the microbiome like diet, physical activity and use of medication.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3920/bm2020.0057

Cites

250 of 250 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The genera Bacteroides, Akkermasia, Faecalibacterium, and Eubacterium can provide physiological functions not always conferred directly by bifidobacteria or lactobacilli, such as production of butyrate, propionate, and other bioactive compounds.

    “Also, these genera can provide physiological functions that are not always conferred directly by bifidobacteria or lactobacilli (the production of butyrate, propionate, and other bioactive) [232].”
  • SCFAs, specifically butyrate, have been implicated in gastrointestinal and metabolic health, exert anti-inflammatory and immunomodulatory properties, and can influence central functioning.

    “SCFAs, specifically butyrate, have been implicated in gastrointestinal (main energy source of colonocytes, supporting gut barrier function) and metabolic (glucose homeostasis, lipid oxidation) health, exert anti-inflammatory and immunomodulatory properties, and can influence central functioning (as outlined in detail below) (119, 120).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 19

  1. Bellahcene, M., O'Dowd, J.F., Wargent, E.T., Zaibi, M.S., Hislop, D.C., Ngala, R.A., Smith, D.M., Cawthorne, M.A., Stocker, C.J. and Arch, J.R., 2013. Male mice that lack the G-protein-coupled receptor GPR41 have low energy expenditure and increased body fat content. British Journal of Nutrition 109: 1755-1764. https://doi.org/10.1017/ · DOI
  2. S0007114512003923 · DOI
  3. Bischoff, S.C., 2011. 'Gut health': a new objective in medicine? BMC Medicine 9: 24. https://doi.org/10.1186/1741-7015-9-24 https://www.wageningenacademic.com/doi/pdf/10.3920/BM2020.0057 -Tuesday, July 27, 2021 5:59:07 AM -IP Address:194.57.135.216 · DOI · Paper page
  4. Darzi, J., Frost, G.S. and Robertson, M.D., 2012. Effects of a novel propionate-rich sourdough bread on appetite and food intake. European Journal of Clinical Nutrition 66: 789-794. https://doi. org/10.1038/ejcn.2012. · DOI
  5. Duncan, S.H., Louis, P. and Flint, H.J., 2004. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Applied and Environmental Microbiology 70: 5810-5817. https://doi.org/10.1128/AEM.70.10.5810-5817.2004 https://www.wageningenacademic.com/doi/pdf/10.3920/BM2020.0057 -Tuesday, July 27, 2021 5:59:07 AM -IP Address:194.57.135.216 · DOI
  6. Guo, C., Xie, S., Chi, Z., Zhang, J., Liu, Y., Zhang, L., Zheng, M., Zhang, X., Xia, D., Ke, Y., Lu, L. and Wang, D., 2016. Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome. Immunity 45: 802-816. https://doi.org/10.1016/j. immuni.2016.09.008 https://www.wageningenacademic.com/doi/pdf/10.3920/BM2020.0057 -Tuesday, July 27, 2021 5:59:07 AM -IP Address:194.57.135.216 · DOI · Paper page
  7. Jia, Y., Hong, J., Li, H., Hu, Y., Jia, L., Cai, D. and Zhao, R., 2016. Butyrate stimulates adipose lipolysis and mitochondrial oxidative phosphorylation through histone hyperacetylation-associated beta3- adrenergic receptor activation in high-fat diet-induced obese mice. Experimental Physiology 102: 273-281. https://doi.org/10.1113/ · DOI
  8. EP086114 · DOI
  9. Jiang, L., Krystal, J.H., Mason, G.F., Jiang, L., Gulanski, B.I., Feyter, H.M.D., Weinzimer, S.A., Pittman, B., Guidone, E., Koretski, J., Harman, S., Petrakis, I.L., Krystal, J.H. and Mason, G.F., 2013. Increased brain uptake and oxidation of acetate in heavy drinkers find the latest version: increased brain uptake and oxidation of acetate in heavy drinkers. Journal of Clinical Investigation 123: 1605-1614. https://doi.org/10.1172/JCI65153. · DOI
  10. by · DOI
  11. Kimura, I., Inoue, D., Maeda, T., Hara, T., Ichimura, A. and Miyauchi, S., 2011. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41. Proceedings of the National Academy of Sciences of the USA 108: 8030-8035. https://doi.org/10.1073/pnas.1016088108/-/ DCSupplemental.www.pnas.org/cgi/doi/10.1073/pnas.1016088108 https://www.wageningenacademic.com/doi/pdf/10.3920/BM2020.0057 -Tuesday, July 27, 2021 5:59:07 AM -IP Address:194.57.135.216 · DOI
  12. Lim, S.S., Vos, T., Flaxman, A.D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M.A., Amann, M., Anderson, H.R., Andrews, K.G., Aryee, M., Atkinson, C., Bacchus, L.J., Bahalim, A.N., Balakrishnan, K., Balmes, J., Barker-Collo, S., Baxter, A., Bell, M.L., Blore, J.D., Blyth, F., Bonner, C., Borges, G., Bourne, R., Boussinesq, M., Brauer, M., Brooks, P., Bruce, N.G., Brunekreef, B., Bryan-Hancock, C., Bucello, C., Buchbinder, R., Bull, F., Burnett, R.T., Byers, T.E., Calabria, B., Carapetis, J., Carnahan, E., Chafe, Z., Charlson, F., Chen, H., Chen, J.S., Cheng, A.T.-A., Child, J.C., Cohen, A., Colson, K.E., Cowie, B.C., Darby, S., Darling, S., Davis, A., Degenhardt, L., Dentener, F., Des Jarlais, D.C., Devries, K., Dherani, M., Ding, E.L., Dorsey, E.R., Driscoll, T., Edmond, K., Ali, S.E., Engell, R.E., Erwin, P.J., Fahimi, S., Falder, G., Farzadfar, F., Ferrari, A., Finucane, M.M., Flaxman, S., Fowkes, F.G.R., Freedman, G., Freeman, M.K., Gakidou, E., Ghosh, S., Giovannucci, E., Gmel, G., Graham, K., Grainger, R., Grant, B., Gunnell, D., Gutierrez, H.R., Hall, W., Hoek, H.W., Hogan, A., Hosgood, H.D., Hoy, D., Hu, H., Hubbell, B.J., Hutchings, S.J., Ibeanusi, S.E., Jacklyn, G.L., Jasrasaria, R., Jonas, J.B., Kan, H., Kanis, J.A., Kassebaum, N., Kawakami, N., Khang, Y.-H., Khatibzadeh, S., Khoo, J.-P., Kok, C., Laden, F., Lalloo, R., Lan, Q., Lathlean, T., Leasher, J.L., Leigh, J., Li, Y., Lin, J.K., Lipshultz, S.E., London, S., Lozano, R., Lu, Y., Mak, J., Malekzadeh, R., Mallinger, L., Marcenes, W., March, L., Marks, R., Martin, R., McGale, P., McGrath, J., Mehta, S., Memish, Z.A., Mensah, G.A., Merriman, T.R., Micha, R., Michaud, C., Mishra, V., Hanafiah, K.M., Mokdad, A.A., Morawska, L., Mozaffarian, D., Murphy, T., Naghavi, M., Neal, B., Nelson, P.K., Nolla, J.M., Norman, R., Olives, C., Omer, S.B., Orchard, J., Osborne, R., Ostro, B., Page, A., Pandey, K.D., Parry, C.D.H., Passmore, E., Patra, J., Pearce, N., Pelizzari, P.M., Petzold, M., Phillips, M.R., Pope, D., Pope, C.A., Powles, J., Rao, M., Razavi, H., Rehfuess, E.A., Rehm, J.T., Ritz, B., Rivara, F.P., Roberts, T., Robinson, C., Rodriguez-Portales, J.A., Romieu, I., Room, R., Rosenfeld, L.C., Roy, A., Rushton, L., Salomon, J.A., Sampson, U., Sanchez-Riera, L., Sanman, E., Sapkota, A., Seedat, S., Shi, P., Shield, K., Shivakoti, R., Singh, G.M., Sleet, D.A., Smith, E., Smith, K.R., Stapelberg, N.J.C., Steenland, K., Stöckl, H., Stovner, L.J., Straif, K., Straney, L., Thurston, G.D., Tran, J.H., Van Dingenen, R., van Donkelaar, A., Veerman, J.L., Vijayakumar, L., Weintraub, R., Weissman, M.M., White, R.A., Whiteford, H., Wiersma, S.T., Wilkinson, J.D., Williams, H.C., Williams, W., Wilson, N., Woolf, A.D., Yip, P., Zielinski, J.M., Lopez, A.D., Murray, C.J.L. and Ezzati, M., 2012. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 380: 2224-2260. https://doi. org/10.1016/s0140-6736(12)61766-8 https://www.wageningenacademic.com/doi/pdf/10.3920/BM2020.0057 -Tuesday, July 27, 2021 5:59:07 AM -IP Address:194.57.135.216 · DOI · Paper page
  13. Cummings, J.H., Rombeau, J.L. and Sakata, S. (eds.) Physiological and clinical aspects of short chain fatty acid metabolism. Cambridge University Press, Cambridge, UK, pp.
  14. Millard, A.L., Mertes, P.M., Ittelet, D., Villard, F., Jeannesson, P. and Bernard, J., 2002. Butyrate affects differentiation, maturation and function of human monocyte-derived dendritic cells and macrophages. Clinical and Experimental Immunology 130: 245- 255. https://doi.org/10.1046/j.0009-9104.2002.01977.x https://www.wageningenacademic.com/doi/pdf/10.3920/BM2020.0057 -Tuesday, July 27, 2021 5:59:07 AM -IP Address:194.57.135.216 · DOI · Paper page
  15. Trinidad, T.P., Wolever, T.M.S. and Thompson, L.U., 1993. Interactive effects of calcium and short chain fatty acids on absorption in the distal colon of man. Nutrition Research: 417-425. https://doi. org/10.1016/s0271 · DOI
  16. Van der Beek, C.M., Bloemen, J.G., Van den Broek, M.A., Lenaerts, K., Venema, K., Buurman, W.A. and Dejong, C.H., 2015. Hepatic uptake of rectally administered butyrate prevents an increase in systemic butyrate concentrations in humans. Journal of Nutrition 145: 2019-2024. https://doi.org/10.3945/jn.115.211193 https://www.wageningenacademic.com/doi/pdf/10.3920/BM2020.0057 -Tuesday, July 27, 2021 5:59:07 AM -IP Address:194.57.135.216 · DOI
  17. cs20160263 · DOI · Paper page
  18. Westerbeek, E.A., Van den Berg, A., Lafeber, H.N., Fetter, W.P. and van Elburg, R.M., 2011. The effect of enteral supplementation of a prebiotic mixture of non-human milk galacto-, fructo-and acidic oligosaccharides on intestinal permeability in preterm infants. British Journal of Nutrition 105: 268-274. https://doi.org/10.1017/ · DOI
  19. S0007114510003405 · DOI

Cited by

Sorted by citations

Authors
Blaak, E. E., Canfora, E. E., Theis, S., Frost, G., Groen, A. K., Mithieux, G., Nauta, A., Scott, K., Stahl, B., van Harsselaar, J., van Tol, R., Vaughan, E. E., & Verbeke, K.
Affiliations
  • Maastricht University (NL)
  • Südzucker (Germany) (DE)
  • Imperial College London (GB)
  • University Medical Center Groningen (NL)
  • Inserm (FR)
  • FrieslandCampina (Netherlands) (NL)
  • University of Aberdeen (GB)
  • Utrecht University (NL)
  • Südzucker Group – Beneo, Wormser Str. 11, Mannheim, 67283, Germany.
  • Reckitt Benckiser/Mead Johnson Nutrition, Middenkampweg 2, 6545 CJ Nijmegen, the Netherlands.
  • Sensus (Royal Cosun), Borchwerf 3, 4704 RG Roosendaal, the Netherlands.
  • KU Leuven (BE)
Venue
Beneficial Microbes
Published
2020-09-01
Volume
11
Issue
5
Pages
411-455
ISSN
  • 1876-2883 (ISSN-L)
  • 1876-2891
OpenAlex
W3080685158
Cited by
1,103
References
250
Citations by year
2026: 161 · 2025: 247 · 2024: 249 · 2023: 199 · 2022: 165 · 2021: 73 · 2020: 5 · 2017: 1
FWCI
10.58
Type
journal article
Language
en
Open access
Locations
  • Beneficial Microbes (publishedVersion, other-oa)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, cc-by-nc-sa)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by-nc-sa)
  • HAL (submittedVersion, other-oa)
  • Lirias (submittedVersion, cc-by-nc-nd)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • Aberdeen University Research Archive (Aberdeen University) (submittedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • Pure Amsterdam UMC (submittedVersion, cc-by)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by-nc-sa)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders
  • National Institute for Health and Care Research (NF-SI-0508-10112, NF-SI-0513-10029)
  • Biotechnology and Biological Sciences Research Council (BBS/E/F/000PR10346, BB/N016947/1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
short-chain fatty acids, gut microbiota, acetate, propionate, butyrate, microbial fermentation, dietary fiber, intestinal barrier, mucosal immunity, appetite regulation, energy expenditure, glucose homeostasis, obesity, type 2 diabetes, gastrointestinal dysfunction, prebiotics
MeSH terms
Gastrointestinal Microbiome, Host Microbial Interactions, Animals, Diabetes Mellitus, Type 2, Fatty Acids, Volatile, Gastrointestinal Diseases, Humans, Obesity, Gastrointestinal Tract, Carbohydrate Metabolism, Prebiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review